ArticleIJID regions2025
Differences found in patient profiles and incidence trends between migrants and native-born tuberculosis patients in Ireland: A cross-sectional analysis of national surveillance data, 2011-2021.
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Tuberculosis (TB) remains a global public health threat that was responsible for 1.3 million deaths in 2022 alone. Although Ireland is a low TB incidence country, with crude incidence rates (CIRs) in the Irish-born below six per 100,000 population since 2011, CIRs in the foreign-born population are up to 13 times higher. This study aims to inform TB prevention and care by analyzing the differences in the epidemiology of TB in native-born and foreign-born populations in Ireland. Methods: A cross-sectional analysis of all TB notifications reported to the Irish TB Surveillance System from 2011-2021 was performed. Temporal trends in CIRs were analyzed using negative-binomial regression. Independent variables selected with a Results: Of the 3364 TB patients, 48% were among migrants. Compared with Irish-born, migrants with TB were younger, had higher odds of living with HIV (odds ratio [OR] 3.8, confidence interval [CI] 1.99-7.73), extrapulmonary disease (OR 3.14, CI 2.09-4.79), infection with drug-resistant strains (OR 2.30, CI 1.37-4.01), and residence in congregate residential settings (OR 2.00, CI 1.34-3.05) with lower odds linkage to outbreaks (OR 0.16, CI 0.09-0.28). Recently arrived migrants with TB had higher proportions of international protection applicants and refugees, pulmonary disease, and people living with HIV. Between 2011 and 2021, a significantly declining temporal trend was present for migrants (incidence rate ratio [IRR] 0.96, CI 0.95-0.98), Irish-born (IRR 0.89; CI 0.86-0.92), and total TB patients (IRR 0.95, CI 0.94-0.96). Between 2017 and 2021, a significantly declining temporal trend was still present in Irish-born (IRR 0.76, CI 0.69-0.83) and total patients (IRR 0.91, CI 0.88-0.95), but the trend was no longer significant among migrants with TB (IRR 0.96, CI 0.91-1.01). Conclusions: A heightened awareness of extrapulmonary TB within health systems is needed, given the high levels observed among migrants with TB. The pace of TB decline among migrants is no longer significantly declining in the final years of this study period, making TB elimination targets more difficult to achieve. Differences in the epidemiology of TB reported by this study can be used to inform and enhance future TB service provision and promote migrant health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.